AIDS News and Research

RSS

International goals to reduce malaria burdens not likely to be achieved

For malaria control goals to be achieved, we must in the future tie funding commitments closer to level of need, says new research by Bob Snow and colleagues from the Kenyan Medical Research Institute-Oxford University-Wellcome Trust Collaborative Programme.

22 Jul 2008

AHF chart shows how Senate global AIDS bill will save five to seven million lives

A chart prepared by AIDS Healthcare Foundation (AHF), which provides AIDS care and treatment services to more than 79,000 individuals in 20 countries worldwide, shows how the Senate version of legislation to re-authorize PEPFAR (the President's Emergency Plan for AIDS Relief), the successful US global AIDS program, will be able to save five to seven million lives over the next five years.

21 Jul 2008

Viral recombination another way HIV fools the immune system

When individuals infected with HIV become infected with a second strain of the virus, the two viral strains can exchange genetic information, creating a third, recombinant strain of the virus. It is known that the presence of multiple viral strains, called superinfection, frequently leads to a loss of immune control of viral levels.

21 Jul 2008

Evolutionary back-and-forth for humans and viruses

For millennia, humans and viruses have been locked in an evolutionary back-and-forth - one changes to outsmart the other, prompting the second to change and outsmart the first.

21 Jul 2008

Trial of new AIDS vaccine bites the dust

Plans to conduct a large-scale human trial of an experimental HIV/AIDS vaccine in the United States have bitten the dust.

21 Jul 2008

HIV-I damages the immune system early than originally thought

New research into the earliest events occurring immediately upon infection with HIV-I shows that the virus deals a stunning blow to the immune system earlier than was previously understood. According to scientists at Duke University Medical Center, this suggests the window of opportunity for successful intervention may be only a matter of days - not weeks - after transmission, as researchers had previously believed.

19 Jul 2008

New discovery on Candida infections

Scientists here have found that certain substances from bacteria living in the human intestine cause the normally harmless Candida albicans fungus to become highly infectious.

17 Jul 2008

NIAID will not conduct the PAVE 100 HIV vaccine study

After soliciting and considering broad input from the scientific and HIV advocacy communities, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has determined that it will not conduct the HIV vaccine study known as PAVE 100.

17 Jul 2008

Genetic resistance to HIV

Some people may be naturally resistant to infection with HIV, the virus that causes AIDS. The results of a study conducted by Dr. Nicole Bernard of the Research Institute of the McGill University Health Centre (MUHC) bring us closer to a genetic explanation. Her study findings were published on July 16 in the journal AIDS.

17 Jul 2008

Superbug breakthrough

The week the government's chief medical officer for England, Sir Liam Donaldson, has announced that the NHS aims to create immunisation against two of the most common superbugs, MRSA and Clostridium difficile, within the next decade. But a research team led by University of Sunderland scientists has made a major breakthrough in the fight against a deadly hospital infection which kills tens of thousands of people every year, and it will be available within the next year.

17 Jul 2008

Gene variant increases HIV risk in Africans

A genetic variation which evolved to protect people of African descent against malaria has now been shown to increase their susceptibility to HIV infection by up to 40 per cent, according to new research. Conversely, the same variation also appears to prolong survival of those infected with HIV by approximately two years.

17 Jul 2008

AIDS Healthcare Foundation treatment proposal accepted by US Senate

AIDS Healthcare Foundation (AHF) which provides AIDS care and treatment services to more than 79,000 individuals in 20 countries worldwide, applauded the U.S. Senate for passing the legislation (vote: 80/16) re-authorizing PEPFAR (the President's Emergency Plan for AIDS Relief), the successful US global AIDS program.

16 Jul 2008

New ways of exploiting medicinal uses of cannabis

Research exploring new ways of exploiting the full medicinal uses of cannabis while avoiding unwanted side-effects will be presented to pharmacologists Tuesday, 15 July by leading scientists attending the Federation of European Pharmacological Societies Congress, EPHAR 2008.

From The University of Manchester 15 Jul 2008

FDA approves Energex Systems non-drug therapy for HIV research

Energex Systems, Inc. announced today that it has been granted approval from the Federal Food and Drug Administration (FDA) to utilize its experimental HemoModulation therapy in a clinical trial of HIV infected patients. The purpose of the study will be to demonstrate safety and monitor viral load changes in patients who are not yet eligible for antiviral drug therapy.

14 Jul 2008

Researchers to compare common ARV as a pill and vaginal gel in unique HIV prevention study

In battle with an epidemic that has outpaced nearly all efforts to contain it, researchers are turning to strategies centered on the same antiretroviral (ARV) drugs that have been used successfully to treat HIV in hopes they will be as effective a stronghold for preventing the virus.

9 Jul 2008

Samaritan Pharmaceuticals granted IND from FDA for HIV drug

Samaritan Pharmaceuticals has announced that it has filed an IND (Investigational New Drug) application for SP-6310 in the treatment of HIV-infected patients with abnormal cortisol levels.

8 Jul 2008

Lost viruses may contribute to AIDS

Weak HIV viruses piggyback onto stronger ones, raising the possibility that the human body may harbor many more HIV viruses capable of replicating and contributing to the development of AIDS than previously thought, according to research published in BioMed Central's open access journal, Retrovirology.

8 Jul 2008

The paradox of anti-HIV vaginal microbicides

With no HIV/AIDS vaccine or cure in sight, vaginal microbicides now in clinical trials are one of the most promising weapons that will protect women against HIV infection. Yet these microbicides could be of more benefit to men than to women, according to a new study co-authored by the University of New South Wales' National Centre in HIV Epidemiology and Clinical Research (NCHECR) and UCLA.

7 Jul 2008

Streamlined consent increases HIV testing among high-risk

AIDS Healthcare Foundation (AHF) today lauded a recent San Francisco study which documented a significant increase in HIV testing rates among high-risk groups who have not had to undergo written consent for the procedure, a study finding which supports a change in testing protocol that the Centers for Disease Control (CDC) first recommended in its revised 2006 guidelines for HIV testing, but a change that has not been widely adopted nationwide.

7 Jul 2008

Complacency combined with risky behaviour could lead to HIV superinfection

Experts say almost every country in the developed world, including Australia, is experiencing significant and consistent rises in the rate of new HIV diagnoses among men who have sex with men (MSM).

7 Jul 2008